🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Demonstrate bioequivalence of guaifenesin in Mucinex® extended release (ER)...
Status
Completed
Location
Multiple Locations
Start Date
2013-06-02
Trial ID
NCT03642262
Treatments Being Tested
The objectives of this study are (a) to determine if drug levels from a sin...
Status
Completed
Location
Pharmaceutical Research Unit
Start Date
2014-06
Trial ID
NCT02157649
Determine bioequivalence, safety and tolerability of guaifenesin extended-r...
Status
Completed
Location
Multiple Locations
Start Date
2009-01-16
Trial ID
NCT03644095
Treatments Being Tested
The objectives of this pivotal study are: 1. to evaluate bioavailability o...
Status
Completed
Location
Pharmaceutical Research Unit
Start Date
2014-10
Trial ID
NCT02572375
Treatments Being Tested
Evaluate the pharmacokinetics (PK), Safety and tolerability of guaifenesin ...
Status
Completed
Location
Multiple Locations
Start Date
2011-06-18
Trial ID
NCT03633448
Treatments Being Tested
The study is designed to meet regulatory requirement outside the US. The do...
Status
Completed
Location
Reckitt Benckiser Study Site
Start Date
2011-09
Trial ID
NCT01537081
Treatments Being Tested
Characterize the relative pharmacokinetics (PK) of 3 marketed products cont...
Status
Completed
Location
Multiple Locations
Start Date
2009-06-30
Trial ID
NCT03643575
The objectives of this study are: a) to assess the feasibility and sensitiv...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-01
Trial ID
NCT01062256
Treatments Being Tested